Lipella Pharmaceuticals Inc. Cash and Restricted Cash
Lipella Pharmaceuticals Inc. (LIPO) had Cash and Restricted Cash of $1.86 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-11-14
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.86M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.78M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.23M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.18M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-09-30 | $1.86M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.78M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.23M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.18M 10-Q · filed 2025-11-14 | |
| 2024-09-30 | $1.35M 10-Q · filed 2025-11-14 | $1.35M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.19M 10-Q · filed 2025-08-14 | $1.19M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.11M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $3.29M 10-Q · filed 2025-11-14 | |
| 2023-09-30 | $2.41M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $3.11M 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $4.02M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $5.12M 10-K · filed 2025-03-28 | |
| 2022-09-30 | $114.77K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $434.98K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $414.40K 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $1.41M 10-K · filed 2024-02-27 | |
| 2020-12-31 | $606.74K 10-K · filed 2023-03-31 |